ROBIN A. CONWIT
National Institute of Neurological Disorders and Stroke · 216 works · 11,569 citations · h-index 48
Top works
- Skeletal Muscle Strength as a Predictor of All-Cause Mortality in Healthy Men
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- Randomized Trial of Thymectomy in Myasthenia Gravis
- Age-Associated Loss of Power and Strength in the Upper Extremities in Women and Men
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus
- Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
- Muscle Quality and Age: Cross-Sectional and Longitudinal Comparisons
- Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
- Improving the Reliability of Stroke Disability Grading in Clinical Trials and Clinical Practice
- Randomized study combining interferon and glatiramer acetate in multiple sclerosis
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design
- The Secondary Prevention of Small Subcortical Strokes (SPS3) Study
- Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- Screen failure data in clinical trials: Are screening logs worth it?
- Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
- The Rankin Focused Assessment—Ambulation: A Method to Score the Modified Rankin Scale with Emphasis on Walking Ability
- Methods for Estimating the Numbers of Motor Units in Human Muscles
- Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial